- Saxagliptin 5mg / Dapagliflozin 10mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Saxagliptin 5mg / Dapagliflozin 10mg tablets | Start Date 12-12-2016 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- A10BD21
BNF | Start Date | End Date |
---|---|---|
Current BNF 06010203 | Start Date 04-04-2022 | End Date |
Previous BNF 06010203 | Start Date 22-08-2017 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
33745311000001109 | 12-12-2016 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Dapagliflozin propanediol monohydrate | Based on Base Substance | Dapagliflozin | 10 mg | |
Saxagliptin hydrochloride | Based on Base Substance | Saxagliptin | 5 mg |
Name
Saxagliptin hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Saxagliptin
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Name
Dapagliflozin propanediol monohydrate
Basis of strength description
Based on Base Substance
BOSS
Dapagliflozin
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
Parent Products
-
VTMSaxagliptin + Dapagliflozin
-
VMP(Current) Saxagliptin 5mg / Dapagliflozin 10mg...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
28 tablet | 4956 | Part VIIIA Category C |